108 related articles for article (PubMed ID: 19586677)
1. Tumor-derived molecular information and outcome in hepatocellular carcinoma.
Hoshida Y
J Hepatol; 2009 Sep; 51(3):595-6; author reply 596-7. PubMed ID: 19586677
[No Abstract] [Full Text] [Related]
2. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
3. Molecular prognostication of liver cancer: end of the beginning.
Thorgeirsson SS; Lee JS; Grisham JW
J Hepatol; 2006 Apr; 44(4):798-805. PubMed ID: 16488507
[No Abstract] [Full Text] [Related]
4. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of hepatocellular carcinoma.
Sherman M
N Engl J Med; 2008 Nov; 359(19):2045-7. PubMed ID: 18923166
[No Abstract] [Full Text] [Related]
6. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of multistage hepatocarcinogenesis.
Sakamoto M; Effendi K; Masugi Y
Jpn J Clin Oncol; 2010 Sep; 40(9):891-6. PubMed ID: 20603246
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular classification of hepatocellular carcinoma.
Llovet JM
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S13-6. PubMed ID: 17969094
[No Abstract] [Full Text] [Related]
9. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
10. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
Yang S; Wang M; You W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of hepatocellular carcinoma anno 2011.
van Malenstein H; van Pelt J; Verslype C
Eur J Cancer; 2011 Aug; 47(12):1789-97. PubMed ID: 21612914
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
13. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
14. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
Inukai T; Furuuchi K; Sugita K; Uno K; Ooi A; Sasaki F; Hamada J; Moriuchi T; Nakazawa S
Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling to predict hepatocellular carcinoma outcome.
Hoshida Y; Villanueva A; Llovet JM
Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):101-3. PubMed ID: 19351279
[No Abstract] [Full Text] [Related]
16. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
Wang SM; Ooi LL; Hui KM
Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
[TBL] [Abstract][Full Text] [Related]
17. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
[TBL] [Abstract][Full Text] [Related]
18. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
[TBL] [Abstract][Full Text] [Related]
19. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
[TBL] [Abstract][Full Text] [Related]
20. [Expression of SOX4 gene and early recurrence of hepatocellular carcinoma: their relationship and the clinical significance].
Zheng JH; Jian ZX; Jin HS; Chen SC; Wang GY
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):818-9. PubMed ID: 20423819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
